Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
479 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06295926 | Serplulimab Combined With CCRT for LS-SCLC. | recruiting | Phase 2 | 96 | Peking Union Medical College HospitalOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT05613738 | 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | N/A | 9 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06387810 |
| Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer(undetermined) |
| unknown |
| Phase 2 |
| 45 |
| Peking Union Medical College HospitalOTHER |
| 1 |
| Jul 10, 2024 |
| clinicaltrials |
| NCT05543954 | 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients | unknown | Early Phase 1 | 60 | Peking Union Medical College HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT05549024 | 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients | recruiting | Early Phase 1 | 90 | Peking Union Medical College HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06489171 | Research on Laparoscopic Fertility-Sparing Surgery in Early-Stage Cervical Cancer | completed | — | 132 | Peking Union Medical College HospitalOTHER | 0 | Jul 5, 2024 | clinicaltrials |
| NCT06474338 | AI Detection of Bladder Tumors Under Endoscopy | recruiting | — | 1,000 | Peking Union Medical College HospitalOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06454968 | Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma. | recruiting | Phase 2 | 45 | Peking Union Medical College HospitalOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT05013086 | 177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive Tumors | unknown | Early Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT04860700 | The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma | completed | Phase 2 | 27 | Peking Union Medical College HospitalOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05248633 | Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma | recruiting | Phase 2 | 220 | Peking Union Medical College HospitalOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06433817 | Spectral CT in Radiotherapy for Cervical Cancer | recruiting | — | 150 | Peking Union Medical College HospitalOTHER | 1 | May 30, 2024 | clinicaltrials |
| NCT06429904 | Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer | active not recruiting | Phase 2 | 31 | Peking Union Medical College HospitalOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT06423066 | Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06421805 | Establishing Prospective Mediastinal Tumor Database of PUMCH(MTDPUMCH) | recruiting | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06410716 | Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06410833 | Belimumab After Rituximab in Resistant Primary Juvenile SS(BRRPJS) | recruiting | Phase 4 | 15 | Peking Union Medical College HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06412952 | 68Ga-NOTA-RM26 PET/CT in Glioma Patients | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05383716 | Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy(NeoP) | active not recruiting | Phase 2 | 80 | Peking Union Medical College HospitalOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06379191 | The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program | completed | N/A | 78 | Peking Union Medical College HospitalOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06379334 | Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population | active not recruiting | — | 180 | Peking Union Medical College HospitalOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06362317 | Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer | unknown | Phase 2 | 300 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06363006 | Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer | recruiting | Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT05075460 | Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma | unknown | Phase 3 | 107 | Peking Union Medical College HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05621824 | A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS | not yet recruiting | — | 900 | Peking Union Medical College HospitalOTHER | 0 | Apr 9, 2024 | clinicaltrials |
| NCT06344832 | SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs | not yet recruiting | — | 40 | Peking Union Medical College HospitalOTHER | 0 | Apr 3, 2024 | clinicaltrials |
| NCT05624463 | Effect of Modified Endotracheal Intubation Protocol Combined With Early Oral Intake on Postoperative Recovery Quality in Thyroid and Parathyroid Surgery | completed | N/A | 200 | Peking Union Medical College HospitalOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT05987098 | BBPA PET/CT in Patients With Malignant Tumors | unknown | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06215651 | Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma | recruiting | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT05861830 | Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) | unknown | Phase 3 | 80 | Peking Union Medical College HospitalOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT05069220 | 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor | recruiting | Early Phase 1 | 150 | Peking Union Medical College HospitalOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT05842317 | Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC | unknown | Phase 1 / Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT06074029 | Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy | unknown | Phase 1 / Phase 2 | 50 | Peking Union Medical College HospitalOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT06241105 | Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer | unknown | Phase 2 | 69 | Peking Union Medical College HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT04568200 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT06006832 | A Prospective Cohort Study of Myasthenia Gravis in China | recruiting | — | 202 | Peking Union Medical College HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT06204354 | Construction of Gynecological Tumor Sample Library | not yet recruiting | — | 2,500 | Peking Union Medical College HospitalOTHER | 0 | Jan 12, 2024 | clinicaltrials |
| NCT06194565 | 99mTc-ABH2 SPECT/CT in Breast Cancer | unknown | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06194630 | Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer | unknown | Early Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06194708 | Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer （NORESTO Study） | recruiting | — | 235 | Peking Union Medical College HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT05574907 | Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01) | unknown | N/A | 72 | Peking Union Medical College HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT05574920 | Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02) | unknown | N/A | 88 | Peking Union Medical College HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT06168032 | COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research | recruiting | N/A | 1,224 | Peking Union Medical College HospitalOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06162325 | Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients | unknown | — | 45 | Peking Union Medical College HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT06155370 | Construction of Gynecological Tumor Organoids | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 0 | Dec 4, 2023 | clinicaltrials |
| NCT06142617 | A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation. | not yet recruiting | Phase 2 | 37 | Peking Union Medical College HospitalOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT05935579 | Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer | unknown | Phase 2 | 40 | Peking Union Medical College HospitalOTHER | 1 | Nov 15, 2023 | clinicaltrials |
| NCT05369221 | Feasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space | completed | Phase 1 | 8 | Peking Union Medical College HospitalOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT05523778 | A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct | unknown | N/A | 78 | Peking Union Medical College HospitalOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT06104085 | 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 27, 2023 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials